Tim Davis, CEO of Raremark, a real world evidence/data organisation in the rare diseases space, discusses the possible implications coronavirus will have on the wider eclinical and RWE/D markets.
For more information on Tim and Raremark, please click here.
Listen to the Podcast below:
